The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The Elusive P2X7 Macropore
Open accessAbstract
ATP, which is released under pathological conditions and is considered a damage-associated molecular pattern (DAMP), activates P2X7 receptors (P2X7Rs), trimeric plasma membrane ion channels selective for small cations. P2X7Rs are partners in NOD-like receptor containing a pyrin (NLRP3) inflammasome activation and promoters of tumor cell growth. P2X7R overstimulation triggers the ATP-dependent opening of a nonselective plasma membrane pore, known as a 'macropore', which allows fluxes of large hydrophilic molecules. The pathophysiological functions of P2X7R are thought to be dependent on activation of this conductance pathway, yet its molecular identity is unknown. Recent reports show that P2X7R permeability to organic solutes is an early and intrinsic property of the channel itself. A better understanding of P2X7R-dependent changes in plasma membrane permeability will allow a rationale development of novel anti-inflammatory and anticancer drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The P2X7 receptor is a trimeric ionotropic receptor that belongs to the P2X family of purinergic receptors, presenting low affinity for ATP (EC50 around 0.3–1.8 mM) and, under prolonged stimulation, can form pores allowing the passage of large hydrophilic molecules [62–64].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [64]
Citations
Cites
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,490
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 622
Pathophysiology and Therapeutic Potential of Purinergic Signaling
Burnstock, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.5 · Cited by 618
Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics
Bannas, P., Hambach, J., & Koch-Nolte, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01603 · Cited by 572
Ischemia Opens Neuronal Gap Junction Hemichannels
Thompson, R. J., Zhou, N., & MacVicar, B. A. (2006) · Science · doi:10.1126/science.1126241 · Cited by 560
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 280
Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells
Pislyagin, Е. А., Kozlovskiy, S., Menchinskaya, E. S., Chingizova, E. A., Николаевна, Л. Г., Gorpenchenko, T. Y., Sabutski, Y. E., Полоник, С. Г., & Aminin, D. L. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115975 · Cited by 23
P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization
Sheng, G., Gao, Y., Ding, Q., Zhang, R., Wang, T., Jing, S., Zhao, H., Ma, T., Wu, H. K., & Yang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03985-z · Cited by 24
Oxidative phosphorylation in HIV-1 infection: impacts on cellular metabolism and immune function
Rodriguez, N., Fortune, T., Hegde, E., Weinstein, M. P., Keane, A. M., Mangold, J. F., & Swartz, T. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1360342 · Cited by 25
TRP ion channels: Proteins with conformational flexibility
López-Romero, A. E., Hernández‐Araiza, I., Torres‐Quiroz, F., Tovar‐y‐Romo, L. B., Islas, L. D., & Rosenbaum, T. (2019) · Channels · doi:10.1080/19336950.2019.1626793 · Cited by 23
Overview of the role of purinergic signaling and insights into its role in cancer therapy
Virgilio, F. D., Vultaggio-Poma, V., Tarantini, M., & Giuliani, A. L. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108700 · Cited by 25
Dunning, K., Martz, A., Peralta, F. A., Cevoli, F., Boué‐Grabot, É., Compan, V., Gautherat, F., Wolf, P., Chataigneau, T., & Grütter, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126542 · Cited by 22
P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
Arnaud-Sampaio, V. F., Bento, C. A., Glaser, T., Adinolfi, E., Ulrich, H., & Lameu, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.966404 · Cited by 23
HSV-1 employs UL56 to antagonize expression and function of cGAMP channels
Blest, H. T. W., Redmond, A., Avissar, J., Barker, J., Bridgeman, A., Fowler, G., Chauveau, L., Hertzog, J., Vendrell, I., Fischer, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114122 · Cited by 21
Adhikary, S. R., Geraghty, N. J., Cuthbertson, P., Sluyter, R., & Watson, D. (2019) · Purinergic Signalling · doi:10.1007/s11302-019-09651-8 · Cited by 22
Adinolfi, E., Marchi, E. D., Grignolo, M., Szymczak, B., & Pegoraro, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813906 · Cited by 22
Acuña‐Castillo, C., Escobar, A. F., García-Gómez, M., Bachelet, V. C., Huidobro-Toro, J. P., Sauma, D., & Barrera‐Avalos, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052495 · Cited by 21
Enlightening activation gating in P2X receptors
Sattler, C., & Benndorf, K. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09850-w · Cited by 21
P2X7 Receptor-Related Genetic Mouse Models – Tools for Translational Research in Psychiatry
Urbina-Treviño, L., von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.876304 · Cited by 23
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Hreich, S. J. D., Hofman, P. M., & Vouret‐Craviari, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119235 · Cited by 21
Macrophage P2Y6R activation aggravates psoriatic inflammation through IL-27-mediated Th1 responses
Yin, L., Zhang, E., Mao, T., Zhu, Y., Ni, S., Li, Y., Liu, C., Fang, Y., Ni, K., Lu, Y., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.06.008 · Cited by 21
Purinergic and Adenosinergic Signaling in Pancreatobiliary Diseases
Faraoni, E. Y., Ju, C., Robson, S. C., Eltzschig, H. K., & Bailey, J. M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.849258 · Cited by 19
He, J., Xiu, F., Chen, Y., Yang, Y., Liu, H., Xi, Y., Liu, L., Li, X., Wu, Y., Luo, H., et al. (2024) · Infection and Immunity · doi:10.1128/iai.00248-23 · Cited by 21
Dioscin ameliorates diabetes cognitive dysfunction via adjusting P2X7R/NLRP3 signal
Lu, Z., Yao, Y., Wang, J., & Peng, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108314 · Cited by 19
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
Gonçalves, M. C. B., Andrejew, R., & Gubert, C. (2022) · CNS Drugs · doi:10.1007/s40263-022-00934-0 · Cited by 19
Rump, A., Smolander, O., Boudinot, S. R., Kanellopoulos, J., & Boudinot, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00113 · Cited by 19
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
Demeules, M., Scarpitta, A., Abad, C., Gondé, H., Hardet, R., Pinto-Espinoza, C., Eichhoff, A. M., Schäfer, W., Haag, F., Koch‐Nolte, F., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01699 · Cited by 23
Purinergic-associated immune responses in neurodegenerative diseases
Carracedo, S., Launay, A., Déchelle-Marquet, P.-A., Faivre, É., Blum, D. L., Delarasse, C., & Boué‐Grabot, É. (2024) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2024.102693 · Cited by 20
The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside
von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109366 · Cited by 19
Zou, Y.-T., Li, J., Chai, J.-Y., Hu, Y., Zhang, W., & Zhang, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149513 · Cited by 20
P2X7 is a cytotoxic receptor….maybe not: implications for cancer
Virgilio, F. D. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09735-w · Cited by 17
Calovi, S., Mut-Arbona, P., Tod, P., Iring, A., Nicke, A., Mato, S., Vizi, E. S., Tønnesen, J., & Sperlágh, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.566251 · Cited by 18
Cx43 hemichannels and panx1 channels contribute to ethanol-induced astrocyte dysfunction and damage
Gómez, G. I., Alvear, T. F., Roa, D. A., Farias-Pasten, A., Vergara, S. A., Mellado, L. A., Martínez-Araya, C. J., Prieto‐Villalobos, J., García‐Rodríguez, C., Sánchez, N., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00493-2 · Cited by 19
Freitas, H. R., Isaac, A. R., Silva, T. M., Diniz, G. O. F., Dabdab, Y. D. S., Bockmann, E. C., Guimarães, M. Z. P., Calaza, K. D. C., Mello, F. G. D., Ventura, A. L. M., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1537-y · Cited by 17
Mai, Y., Guo, Z., Yin, W., Zhong, N., Dicpinigaitis, P. V., & Chen, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.691956 · Cited by 17
Westerlund, E., Valfridsson, C., Yi, D. X., & Persson, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01385 · Cited by 17
Flores‐Muñoz, C., Maripillán, J., Vásquez-Navarrete, J., Novoa-Molina, J., Ceriani, R., Sánchez, H. A., Abbott, A. C., Oppenheimer, C. W., Brown, D. I., Cárdenas, A. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031069 · Cited by 17
Childers, G. M., Perry, C. A., Blachut, B., Martin, N. P., Bortner, C. D., Sieber, S. O., Li, J., Fessler, M. B., & Harry, G. J. (2021) · Environmental Health Perspectives · doi:10.1289/ehp8314 · Cited by 16
Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists
Patberg, M., Isaak, A., Füsser, F. T., Zacarı́as, N. V. O., Vinnenberg, L., Schulte, J., Michetti, L., Grey, L., van der Horst, C., Hundehege, P., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113838 · Cited by 16
The Purinergic Landscape of Type 2 Diabetes Mellitus
García-Jacobo, R. E., Bergamin, L. S., Vultaggio-Poma, V., Thorstenberg, M. L., Tarantini, M., García-Hernández, M. H., & Virgilio, F. D. (2022) · Molecules · doi:10.3390/molecules27061838 · Cited by 16
Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models in vivo
Demeules, M., Scarpitta, A., Hardet, R., Gondé, H., Abad, C., Blandin, M., Menzel, S., Duan, Y., Rissiek, B., Magnus, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012534 · Cited by 15
Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas
Hey, G. E., Rao, R., Carter, A. M., Reddy, A., Valle, D., Patel, A., Patel, D., Lucke-Wold, B. P., Krummel, D. P., & Sengupta, S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13050853 · Cited by 16
Human P2X7 receptors – Properties of single ATP-gated ion channels
Markwárdt, F. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114307 · Cited by 16
Mut-Arbona, P., & Sperlágh, B. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109541 · Cited by 16
Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
Volonté, C., Amadio, S., Liguori, F., & Fabbrizio, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01148 · Cited by 15
Denis, M. F. L., Lefevre, S. D., Alvarez, C., Lauri, N., Enrique, N., Rinaldi, D. E., González‐Lebrero, R. M., Dezillio, L. E. V., Espelt, M. V., Stringa, P. L., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.01.018 · Cited by 15
Stimulation of P2X7 Enhances Whole Body Energy Metabolism in Mice
Giacovazzo, G., Fabbrizio, P., Apolloni, S., Coccurello, R., & Volonté, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00390 · Cited by 14
Francistiová, L., Vörös, K., Lovász, Z., Dinnyés, A., & Kobolák, J. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.793769 · Cited by 14
Agonists, Antagonists, and Modulators of P2X7 Receptors
Müller, C. E., & Namasivayam, V. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2384-8_2 · Cited by 14
Understanding interspecies drug response variations between human and rodent P2X7 receptors
Guo, C.-R., Sheng, D., Li, J., Li, T., Yao, J., Zhang, R., Huang, Y., Zhao, Y., Wang, D., Chen, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65847-0 · Cited by 13
Role of the P2X7 receptor in breast cancer progression
Du, Y., Cao, Y., Song, W., Wang, X., Yu, Q., Peng, X., & Zhao, R. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10039-6 · Cited by 13
P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases
Cisneros-Mejorado, A., Pérez‐Samartín, A., Domercq, M., Arellano, R. O., Gottlieb, M., Koch‐Nolte, F., & Matute, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00092 · Cited by 16
Ledderose, S., Rodler, S., Eismann, L., Ledderose, G., Rudelius, M., JUNGER, W. G., & Ledderose, C. (2023) · Cancers · doi:10.3390/cancers15082321 · Cited by 13
The P2X7 purinergic receptor in intervertebral disc degeneration
Penolazzi, L., Bergamin, L. S., Lambertini, E., Vultaggio-Poma, V., Sarti, A. C., BONIS, P. D., Virgilio, F. D., & Piva, R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30611 · Cited by 12
Sawai, Y., Suzuki, Y., Asagiri, M., Hida, S., Kondo, R., Zamponi, G. W., Giles, W. R., Imaizumi, Y., & Yamamura, H. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00303.2023 · Cited by 13
Puro, D. G. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00086.2020 · Cited by 12
Kristóf, Z., Baranyi, M., Tod, P., Mut-Arbona, P., Demeter, K., Bitter, I., & Sperlágh, B. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac026 · Cited by 13
Zhang, Y., Yin, H., Rubini, P., Illés, P., & Tang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.944541 · Cited by 13
Altered purinergic receptor expression in the frontal cortex in schizophrenia
Alnafisah, R. S., Lundh, A., Asah, S. M., Hoeflinger, J., Wolfinger, A., Hamoud, A.-R. A., McCullumsmith, R. E., & O'Donovan, S. M. (2022) · Schizophrenia · doi:10.1038/s41537-022-00312-1 · Cited by 12
Mechanosensitive ATP release in the lungs: New insights from real-time luminescence imaging studies
Grygorczyk, R., Boudreault, F., Tan, J. J., Ponomarchuk, O., Sokabe, M., & Furuya, K. (2019) · Current topics in membranes · doi:10.1016/bs.ctm.2019.02.001 · Cited by 12
Üstündağ, H. (2026) · Purinergic Signalling · doi:10.1007/s11302-026-10140-y · Cited by 12
Durner, A., Durner, E., & Nicke, A. (2023) · eLife · doi:10.7554/elife.82479 · Cited by 11
The Role of P2X7 Purinoceptors in the Pathogenesis and Treatment of Muscular Dystrophies
Zabłocki, K., & Górecki, D. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119434 · Cited by 11
Su, K., Li, X., Hong, F., Jin, M., & Xue, F.-S. (2023) · Inflammation Research · doi:10.1007/s00011-023-01810-3 · Cited by 11
Li, M., Luo, S., Zhang, Y., Jia, L., Yang, C., Peng, X., & Zhao, R. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10340-0 · Cited by 11
Mechanosensitive release of ATP in the urinary bladder mucosa
Mutafova–Yambolieva, V. N. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10063-6 · Cited by 10
Design, Synthesis, and in vitro Evaluation of P2X7 Antagonists
Pournara, D. T., Durner, A., Kritsi, E., Papakostas, A., Zoumpoulakis, P. G., Nicke, A., & Koufaki, M. (2020) · ChemMedChem · doi:10.1002/cmdc.202000303 · Cited by 10
Unorthodox localization of P2X7 receptor in subcellular compartments of skeletal system cells
Penolazzi, L., Notarangelo, M. P., Lambertini, E., Vultaggio-Poma, V., Tarantini, M., Virgilio, F. D., & Piva, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1180774 · Cited by 9
Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential
Immanuel, T., Li, J., Green, T. N., Bogdanova, A. Y., & Kalev‐Zylinska, M. L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1010506 · Cited by 9
Virulence and molecular adaptation of human urogenital mycoplasmas: a review
Roachford, O. S. E., Nelson, K. E., & Mohapatra, B. R. (2019) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1607556 · Cited by 9
ATP-gated P2X7 receptor as a potential target for prostate cancer
Qiao, C., Tang, Y., Li, Q., Zhu, X., Peng, X., & Zhao, R. (2022) · Human Cell · doi:10.1007/s13577-022-00729-x · Cited by 11
Progress in the relationship between P2X7R and colorectal cancer
Bai, X., Li, X., Qiao, C., Tang, Y., Zhao, R., & Peng, X. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07939-4 · Cited by 9
Strayer, A. L., Dennys, C. N., Ricart, K. C., Bae, N., Beckman, J. S., Franco, M. C., & Estévez, Á. G. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219853798 · Cited by 10
Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis
Laketa, D., & Lavrnja, I. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04104-9 · Cited by 9
A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018–present)
Iqbal, J., Bano, S., Khan, I. A., & Huang, Q. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2363885 · Cited by 8
Sierra‐Marquez, J., Schaller, L., Sassenbach, L., Ramírez-Fernández, A., Alt, P., Rissiek, B., Zimmer, B., Schredelseker, J., Hector, J., Stähler, T., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425938 · Cited by 8
Inflammasomes: potential therapeutic targets in hematopoietic stem cell transplantation
Luo, J., Zhou, Y., Wang, M., Zhang, J. L., & Jiang, E. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01974-3 · Cited by 9
New insights into pathogenisis and therapies of P2X7R in Parkinson’s disease
Wei, S., Song, X., Mou, Y., Yang, T., Wang, H., Wang, H., Ren, C., & Song, X. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00980-7 · Cited by 10
A live-cell assay for the real-time assessment of extracellular ATP levels
Niles, A. L., Cali, J. J., & Lazar, D. F. (2021) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114286 · Cited by 8
The role of extracellular ATP and P2X receptors in the pathogenesis of HIV-1
Rodriguez, N., Fortune, T., Vuong, T., & Swartz, T. H. (2023) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2023.102358 · Cited by 8
Deficiency of purinergic P2X4 receptor alleviates experimental autoimmune hepatitis in mice
Liu, Z., Sun, M., Liu, W., Feng, F., Li, X., Jin, C., Zhang, Y., & Wang, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116033 · Cited by 8
Magni, L., Yu, H., Christensen, N. M., Poulsen, M. H., Frueh, A., Deshar, G., Johansen, A. Z., Johansen, J. S., Pless, S. A., Jørgensen, N. R., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03339-9 · Cited by 8
Branco, M. S. L. A., Cruz, A. G., Peri, L. E., & Mutafova–Yambolieva, V. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129964 · Cited by 8
Kristóf, Z., Gál, Z., Török, D., Eszlári, N., Sütöri, S., Sperlágh, B., Anderson, I. M., Deakin, J. F. W., Bagdy, G., Juhász, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020865 · Cited by 7
Genetic Variations in the P2X7 Receptor: Opportunities and Challenges for Drug Development
Cheah, J. S. Y., Skarratt, K. K., Fuller, S. J., & Balle, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110265 · Cited by 7
The multifaceted role of extracellular ATP in sperm function: From spermatogenesis to fertilization
Cao, H., Li, L., Liu, S., Wang, Y., Liu, X., Yang, F., & Dong, W. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.10.019 · Cited by 9
Calcium Signalling in Microglia
Garaschuk, O., & Verkhratsky, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_7 · Cited by 7
Yu, Q., Peng, X., Xu, G., Bai, X., Cao, Y., Du, Y., Wang, X., & Zhao, R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177421 · Cited by 7
Carboxyl terminus of Pannexin-1 plays a crucial role in P2X7 receptor-mediated signaling
Purohit, R., & Bera, A. K. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.04.081 · Cited by 7
P2X7: a receptor with a split personality that raises new hopes for anti-cancer therapy
Sarti, A. C., Vultaggio-Poma, V., & Virgilio, F. D. (2021) · Purinergic Signalling · doi:10.1007/s11302-021-09783-w · Cited by 7
Zhang, K., Ran, R., Zhang, C., Wang, L., & Zhang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1555732 · Cited by 6
Zhang, S., Bi, Y., Xiang, K., & Tang, Y. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70078 · Cited by 7
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies
Górecki, D. C., & Rumney, R. M. H. (2023) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2023.102357 · Cited by 6
P2X7 receptors and pannexin1 hemichannels shape presynaptic transmission
Vitureira, N., Rafael, A., & Abudara, V. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09965-8 · Cited by 7
Influence of extracellular ATP on mammalian sperm physiology
López‐González, I., Oseguera-López, I., Castillo, R., & Darszon, A. (2024) · Reproduction Fertility and Development · doi:10.1071/rd23227 · Cited by 6
Purinergic Ca2+ Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma
Stauffer, P. E., Brinkley, J., Jacobson, D. A., Quaranta, V., & Tyson, D. R. (2024) · Cancers · doi:10.3390/cancers16132426 · Cited by 8
Flow cytometry: An accurate tool for screening P2RX7 modulators
Barczyk, A., Roy, H. B., Jouy, N., Renault, N., Hottin, A., Millet, R., Vouret‐Craviari, V., Adriouch, S., Idziorek, T., & Dezitter, X. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24287 · Cited by 6
Purinergic P2X7R as a potential target for pancreatic cancer
Yu, Q., Wang, X., Li, X., Bai, X., Zhao, R., & Peng, X. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03123-7 · Cited by 6
Knockout and Knock-in Mouse Models to Study Purinergic Signaling
Rumney, R. M. H., & Górecki, D. C. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9717-6_2 · Cited by 6
Muthukumarasamy, I., Buel, S. M., Hurley, J., & Dordick, J. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1731888 · Cited by 5
Antinociceptive effect and anti-inflammatory activity of 1,4-naphthoquinones in mice
Kozlovskiy, S., Pislyagin, Е. А., Menchinskaya, E. S., Chingizova, E. A., Sabutski, Y. E., Полоник, С. Г., Агафонова, И. Г., & Aminin, D. L. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00035 · Cited by 5
P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
Fan, Z., Wang, K., Zhao, X., & Sun, X. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0775 · Cited by 5
Channel plan: control of adaptive immune responses by pannexins
Santiago-Carvalho, I., Ishikawa, M., & da Silva, H. B. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.09.009 · Cited by 5
Research Progress in the Relationship Between P2X7R and Cervical Cancer
Tang, Y., Qiao, C., Li, Q., Zhu, X., Zhao, R., & Peng, X. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01022-w · Cited by 5
Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
Hreich, S. J. D., Juhel, T., Hofman, P. M., & Vouret‐Craviari, V. (2023) · Biological Procedures Online · doi:10.1186/s12575-022-00188-6 · Cited by 5
How is the P2X7 receptor signaling pathway involved in epileptogenesis?
Wei, C., Fu, M., Zhang, H., & Yao, B. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105675 · Cited by 6
Metadata
- Authors
- Di Virgilio, F., Schmalzing, G., & Markwardt, F.
- Affiliations
- RWTH Aachen University (DE)
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 28
- Issue
- 5
- Pages
- 392-404
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W2787249947
- Cited by
- 279
- References
- 96
- Citations by year
- 2026: 23 · 2025: 22 · 2024: 41 · 2023: 44 · 2022: 31 · 2021: 30 · 2020: 33 · 2019: 37 · 2018: 17
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, cc-by-nc-nd)
- Funders
- Italian Association for Cancer Research (13025, 18581)
- Ministry of Health of Italy (RF-2011-02348435)
- University of Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- P2X7 receptor, ATP, plasma membrane permeability, NLRP3 inflammasome, damage-associated molecular patterns, ion channel conductance, anti-inflammatory agents, anticancer agents
- MeSH terms
- Alarmins, NLR Family, Pyrin Domain-Containing 3 Protein, Adenosine Triphosphate, Cell Membrane Permeability, Humans, Neoplasms, Signal Transduction, Cell Proliferation, Receptors, Purinergic P2X7, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review